Press release
Unlocking Opportunities in the Anti-Hypertensive Drugs Market: 2025-2034 Forecast Report
Anti-Hypertensive Drugs
How Large Will the Anti-Hypertensive Drugs Market Size By 2025?
In recent times, the anti-hypertensive drugs market has witnessed substantial growth. The market size, which was $36.66 billion in 2024, is projected to elevate to $37.5 billion in 2025, signifying a compound annual growth rate (CAGR) of 2.3%. The development during the past period is a result of environmental factors, lifestyle changes, past market competitive landscape, traditional treatment choices, economic scenarios, as well as previous global health trends.
How Big Is the Anti-Hypertensive Drugs Market Size Expected to Grow by 2029?
In the coming years, the market size for anti-hypertensive drugs is projected to experience a slight increase, with an expected value of $40.41 billion in 2029 and a compound annual growth rate (CAGR) of 1.9%. The anticipated growth during this period can be credited to factors such as cost-effectiveness and accessibility, the advent of therapeutic breakthroughs, epidemiological tendencies, regulatory alterations and approvals, changes in demographics due to aging, as well as shifts in healthcare policies and reimbursements. Key trends over the forecast duration encompass therapeutic innovation, epidemiological transitions, changes in the regulatory sphere, modifications in healthcare policies, and progress in diagnostic and monitoring technology.
View the full report here:
https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report
Which Key Market Drivers Powering Anti-Hypertensive Drugs Market Expansion and Growth?
The primary factor driving the expansion of the anti-hypertensive drug market is the widespread prevalence of sedentary lifestyles. An unhealthy diet characterized by high consumption of junk food, the absence of wholesome and balanced meals, and lack of sufficient sleep due to erratic work schedules are all contributing factors to the rise in hypertension. Hypertension is the root cause of at least 45% of heart disease-related deaths and 51% of strokes. Once a diagnosis of hypertension is made, depending on disease severity, patients need to take medication to keep it under control. For example, as per the National Health Service, a government agency based in England, hypertension prevalence increases with age. It begins at 9% in adults aged 16-44 and escalates to 60% amongst individuals aged 65 and above as of May 2023. This consistent demand for anti-hypertensive drugs is a significant factor propelling the market's growth.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2410&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Anti-Hypertensive Drugs Market?
Leading companies in the anti-hypertensive drugs market are concentrating on product innovation, such as Metoprolol Succinate Extended-Release Tablets to establish a competitive advantage in the marketplace. These tablets are utilized as anti-hypertensive medication for individuals suffering from high blood pressure. For example, in June 2023, Granules India Limited, a pharmaceutical manufacturer based in India, introduced Metoprolol Succinate Extended-Release Tablets that had received FDA approval. These tablets are a type of anti-hypertensive medication specifically developed to treat hypertension and help reduce blood pressure. They come in various potencies, such as 25mg, 50mg, 100mg, and 200mg. They contain beta-blockers that decelerate the heart rate, lessen the heart's workload, and subsequently decrease blood pressure.
What Are the Emerging Segments in the Anti-Hypertensive Drugs Market?
The anti-hypertensive drugs market covered in this report is segmented -
1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators
2) By Disease Source: Primary Hypertension, Secondary Hypertension
3) By End Users: Hospitals, Clinics, Homecare
Subsegments:
1) By Diuretics: Thiazide Diuretics, Loop Diuretics, Potassium-Sparing Diuretics
2) By Angiotensin Receptor Blockers (ARBs): Losartan, Valsartan, Irbesartan, Candesartan
3) By Angiotensin Converting Enzyme (ACE) Inhibitors: Enalapril, Lisinopril, Ramipril, Benazepril
4) By Beta Blockers: Metoprolol, Atenolol, Carvedilol, Bisoprolol
5) By Alpha Blockers: Doxazosin, Prazosin, Terazosin
6) By Calcium Channel Blockers: Amlodipine, Diltiazem, Verapamil, Nifedipine
7) By Renin Inhibitors: Aliskiren
8) By Vasodilators: Hydralazine, Minoxidil
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2410&type=smp
Who Are the Global Leaders in the Anti-Hypertensive Drugs Market?
Major companies operating in the anti-hypertensive drugs market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbiVe Inc., Bayer AG, Novartis AG, Sanofi SA, Astra Zeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, C.H. Boehringer Sohn AG & Ko. KG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Fresenius Kabi AG, Sun Pharmaceuticals LLC, Cipla Limited, Dr. Reddy's Laboratories, Hikma Pharmaceuticals PLC, Lupin Limited, Torrent Pharmaceuticals Ltd, Noden Pharma DAC, Actelion Pharmaceuticals Ltd.
Which are the Top Profitable Regional Markets for the Anti-Hypertensive Drugs Industry?
North America was the largest region in the anti-hypertensive drugs market in 2024. The Middle East is expected to be the largest growing region in the global anti-hypertensive drugs market during the forecast period. The regions covered in the anti-hypertensive drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2410
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Unlocking Opportunities in the Anti-Hypertensive Drugs Market: 2025-2034 Forecast Report here
News-ID: 4110243 • Views: …
More Releases from The Business Research Company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
